Fate Therapeutics (FATE) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]
Fate Therapeutics, Inc. (FATE)
Last fate therapeutics, inc. earnings: 3/2 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.fatetherapeutics.com/investor-relations
Company Research
Source: Yahoo! Finance
Fate Therapeutics (FATE) came out with a quarterly loss of $0.27 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.31 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +1.21%. A quarter ago, it was expected that this clinical-stage biotech company that develops stem cell treatments would post a loss of $0.29 per share when it actually produced a loss of $0.27, delivering a surprise of +6.9%. Over the last four quarters, the company has surpassed consensus EPS estimates four times. Fate Therapeutics, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $1.37 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 8.73%. This compares to year-ago revenues of $1.86 million. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's imme
Show less
Read more
Impact Snapshot
Event Time:
FATE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FATE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FATE alerts
High impacting Fate Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
FATE
News
- Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates [Yahoo! Finance]Yahoo! Finance
- Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business UpdatesGlobeNewswire
- ?????????????????????:2032???11750???????????? [CNET News]CNET News
- Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
FATE
Earnings
- 11/13/25 - Beat
FATE
Sec Filings
- 2/26/26 - Form 10-K
- 2/26/26 - Form 8-K
- 1/16/26 - Form 4
- FATE's page on the SEC website